In agreement, exposure of CML cells to imatinib inhibited FoxO3a phosphorylation and induced p27/kip1 expression and G0/G1 arrest, blocking cell cycle progression. This evidence concerns the gene FOXO3 and chronic myelogenous leukemia, BCR-ABL1 positive.